Longevity Series A Investors & VC Firms

155 firms in this list, with a median first check of $450K. 39 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Time BioVentures 16 people	Southern California	US	Seed–Series A	—	+ Add to CRM
Brookstreet Equity Partners 20 people	London	GB	Pre-Seed–Growth	—	+ Add to CRM
Fund+ 11 people	Leuven	BE	Series A–Series B	$5.5M – $16.5M	+ Add to CRM
age1 9 people · Leads rounds	San Francisco	US	Pre-Seed–Series A	$500K – $4M	+ Add to CRM
Coyote Ventures 14 people · Follows rounds	San Francisco	US	Pre-Seed–Series A	—	+ Add to CRM
Magnetic Ventures 9 people · Leads rounds	Boston	US	Seed–Series A	$1M – $6M	+ Add to CRM
Lifetime Ventures 5 people	Okinawa	JP	Pre-Seed–Growth	—	+ Add to CRM
Auriga Partners 15 people	Paris	FR	Seed–Growth	$540K – $5.4M	+ Add to CRM
Iaso Ventures 10 people	Cambridge	US	Seed–Series A	—	+ Add to CRM
Equitage Ventures, L.L.C. 9 people	Denver	US	Pre-Seed–Late Stage	$250K – $2.5M	+ Add to CRM
Selva Ventures 6 people · Leads rounds	Los Angeles	US	Seed–Series A	$100K – $5M	+ Add to CRM
Northern Gritstone 6 people · Follows rounds	—	GB	Pre-Seed–Growth	—	+ Add to CRM
Overwater Ventures Llc 7 people · Leads rounds	Palo Alto	US	Pre-Seed–Series A	$400K – $2M	+ Add to CRM
GIMIC Ventures 6 people	Karlsruhe	DE	Pre-Seed–Series A	$220K – $2.2M	+ Add to CRM
Harmonix Fund 6 people	La Quinta	US	Pre-Seed–Late Stage	—	+ Add to CRM
Stone Mountain Ventures 1 person	Dallas	US	Pre-Seed–Series A	$5M	+ Add to CRM
CABHI Ventures 9 people	Toronto	CA	Pre-Seed–Series A	—	+ Add to CRM
AgeTech Capital 15 people	Toronto	CA	Pre-Seed–Growth	—	+ Add to CRM
AdBio partners 3 people	Paris	FR	Pre-Seed–Series A	—	+ Add to CRM
Seed Healthcare 12 people	Dorado	US	Pre-Seed–Series A	—	+ Add to CRM
Todd and Rahul’s Angel Fund 2 people · Follows rounds	San Francisco	US	Pre-Seed–Series A	$300K – $500K	+ Add to CRM
Aescap Life Sciences 14 people	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
Pave Health Ventures 12 people	Seattle	US	Pre-Seed–Series A	—	+ Add to CRM
Blackstone Life Sciences 9 people	New York	US	Series A–Late Stage	$20M – $60M	+ Add to CRM